- Home
- VERA vs BHC Comparison
VERA vs BHC Comparison
Compare VERA & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERA
- BHC
- Stock Information
- Founded
- VERA 2016
- BHC N/A
- Country
- VERA United States
- BHC Canada
- Employees
- VERA N/A
- BHC N/A
- Industry
- VERA Biotechnology: Pharmaceutical Preparations
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- VERA Health Care
- BHC Health Care
- Exchange
- VERA Nasdaq
- BHC Nasdaq
- Market Cap
- VERA 2.0B
- BHC 2.3B
- IPO Year
- VERA 2021
- BHC N/A
- Fundamental
- Price
- VERA $23.20
- BHC $6.41
- Analyst Decision
- VERA Buy
- BHC Hold
- Analyst Count
- VERA 8
- BHC 5
- Target Price
- VERA $64.63
- BHC $7.20
- AVG Volume (30 Days)
- VERA 1.3M
- BHC 2.3M
- Earning Date
- VERA 08-07-2025
- BHC 07-30-2025
- Dividend Yield
- VERA N/A
- BHC N/A
- EPS Growth
- VERA N/A
- BHC N/A
- EPS
- VERA N/A
- BHC N/A
- Revenue
- VERA N/A
- BHC $9,731,000,000.00
- Revenue This Year
- VERA N/A
- BHC $3.71
- Revenue Next Year
- VERA N/A
- BHC $5.03
- P/E Ratio
- VERA N/A
- BHC N/A
- Revenue Growth
- VERA N/A
- BHC 8.53
- 52 Week Low
- VERA $18.53
- BHC $3.96
- 52 Week High
- VERA $51.61
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- VERA 49.75
- BHC 56.27
- Support Level
- VERA $22.57
- BHC $6.23
- Resistance Level
- VERA $24.58
- BHC $7.24
- Average True Range (ATR)
- VERA 1.13
- BHC 0.26
- MACD
- VERA 0.06
- BHC -0.09
- Stochastic Oscillator
- VERA 38.05
- BHC 17.31
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.